ALS Therapy Development Institute

The ALS Therapy Development Institute (ALS TDI) is a non-profit biotechnology research organization focused on finding treatments for amyotrophic lateral sclerosis (ALS). With a staff including more than 30 scientists, it operates a research and development program centered on ALS.

ALS Therapy Development Institute
AbbreviationALS TDI
Founded1999
Founder
Typenon-profit biotech
04-3462719
Location
Key people
  • Augie Nieto (chairman of the board)
  • Steven Perrin, PhD (vice chairman of the board)
  • Fernando Vieira, M.D. (chief executive officer and chief scientific officer)
AffiliationsInternational Alliance of ALS/MND Associations
Websiteals.net
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.